ClinicalTrials.govpublic full text
Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer
female, age ≥ 18 years old, no previous systemic treatment for the current disease, including surgery, antitumor radiochemotherapy/immunotherapy, ecog score of 0-1, histologically confirmed cervical cancer, figo stage ib3, iia2, iib, iiic, and assessed by the researcher as resectable lesion, sufficient organ function, the result of the urine or serum pregnancy test for the subject is negative
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 127573
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.